Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

  • There is currently no data for DEMG

Additional Listing

16 Oct 2007 16:03

Deltex Medical Group PLC16 October 2007 16 October 2007 Deltex Medical Group plc Additional Listing Deltex Medical Group plc (the 'Company') was notified yesterday that certain ofits current employees have acquired 11,268 ordinary shares of 1p each as theresult of the exercise of an option under the Company's Enterprise ManagementIncentive Scheme exercisable over 11,268 shares at a price of 1 pence perordinary share. In addition, the Company' was also notified yesterday that certain of itscurrent employees have acquired a further 5,000 ordinary shares of 1p each asthe result of the exercise of an option under the Company's Executive ShareOption Scheme exercisable over 5,000 shares at a price of 15 pence per ordinaryshare. Accordingly, application has been made for 16,268 new ordinary shares to beadmitted to trading. The new ordinary shares will rank pari passu with theexisting issued shares of the Company and dealings are expected to commence on22 October 2007. Following this, the total number of voting rights in issue will be 92,487,907. Enquiries: Deltex Medical Group plc 01243 774 837Ewan Phillips / Paul Mitchell Charles Stanley Securities 0207 149 6000 Nominated Adviser Philip Davies / Carl Holmes This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Feb 20237:00 amRNSConvertible loan notes repayment date extension
24th Jan 20237:00 amRNSYear end trading update
22nd Dec 20227:00 amRNSYear end update
20th Sep 20227:00 amRNSInterim Results
14th Jul 20227:00 amRNSCompletion of Nominated Adviser due diligence
7th Jul 20227:00 amRNSHalf year trading update
18th May 20223:41 pmRNSResult of AGM
18th May 20227:00 amRNSChairman's Statement to Annual General Meeting
28th Apr 20227:00 amRNSChange of Adviser
7th Apr 20227:00 amRNSResults for the year ended 31 December 2021
2nd Mar 20224:30 pmRNSHolding(s) in Company
17th Feb 20224:02 pmRNSGrant of options
8th Feb 20227:00 amRNSSubscription and extension of Debt Facility
26th Jan 20227:00 amRNSContract win in the Americas
12th Jan 20227:00 amRNSIssue of Equity
11th Jan 20227:00 amRNSPre-close statement
20th Dec 20217:00 amRNSSuccessful Innovate UK Smart Award
20th Sep 20217:00 amRNSInterim results to 30 June 2021
22nd Jul 20213:48 pmRNSIssue of Equity
16th Jul 20217:00 amRNSIssue of Equity
8th Jul 20217:00 amRNSPre-close trading update
30th Jun 20212:06 pmRNSPosting of Accounts
28th May 20217:00 amRNSResult of AGM
27th May 20217:00 amRNSAGM Statement
28th Apr 20217:00 amRNSGrant of options
22nd Apr 20217:00 amRNSResults for the year ended 31 December 2020
13th Apr 202112:30 pmRNSNotice of results, AGM and investor presentation
30th Mar 202112:38 pmBUSEarly Repurchase - Replacement
29th Mar 202110:06 amBUSEarly Repurchase
9th Feb 202110:31 amRNSDirector Dealing
20th Jan 20217:00 amRNSPre-Close Statement and Director Appointment
5th Jan 20211:21 pmRNSHolding(s) in Company
24th Dec 20209:30 amRNSHolding(s) in Company
21st Dec 20207:00 amRNSUpdate on commercial activity and issue of equity
22nd Sep 20204:03 pmRNSDirector Dealing
21st Sep 20207:00 amRNSInterim results to 30 June 2020
3rd Aug 20209:38 amRNSHolding(s) in Company
22nd Jul 20207:00 amRNSGrant of Options
14th Jul 20209:17 amRNSHolding(s) in Company
9th Jul 20207:00 amRNSPre-close Trading Update
17th Jun 20205:00 pmRNSPosting of Accounts
3rd Jun 20203:43 pmRNSResult of AGM
3rd Jun 20207:00 amRNSAGM Statement
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSResults for the year ended 31 December 2019
24th Apr 20203:39 pmRNSNotice of Results
6th Apr 20202:06 pmRNSSecond Price Monitoring Extn
6th Apr 20202:00 pmRNSPrice Monitoring Extension
12th Mar 202012:36 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.